274 related articles for article (PubMed ID: 26465753)
1. λ-Carrageenan P32 Is a Potent Inhibitor of Rabies Virus Infection.
Luo Z; Tian D; Zhou M; Xiao W; Zhang Y; Li M; Sui B; Wang W; Guan H; Chen H; Fu ZF; Zhao L
PLoS One; 2015; 10(10):e0140586. PubMed ID: 26465753
[TBL] [Abstract][Full Text] [Related]
2. Aptamers targeting rabies virus-infected cells inhibit viral replication both in vitro and in vivo.
Liang HR; Liu Q; Zheng XX; Gai WW; Xue XH; Hu GQ; Wu HX; Wang HL; Yang ST; Xia XZ
Virus Res; 2013 May; 173(2):398-403. PubMed ID: 23333291
[TBL] [Abstract][Full Text] [Related]
3. Cationic amphiphilic drugs enhance entry of lentiviral particles pseudotyped with rabies virus glycoprotein into non-neuronal cells.
Klintworth A; Nolden T; Westhaus S; Rohrmann K; David S; Manns MP; Finke S; Ciesek S; von Hahn T
Antiviral Res; 2015 Dec; 124():122-31. PubMed ID: 26542648
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus.
Anindita PD; Sasaki M; Okada K; Ito N; Sugiyama M; Saito-Tarashima N; Minakawa N; Shuto S; Otsuguro S; Ichikawa S; Matsuda A; Maenaka K; Orba Y; Sawa H
Antiviral Res; 2018 Jun; 154():1-9. PubMed ID: 29601893
[TBL] [Abstract][Full Text] [Related]
5. Selection of an aptamer against rabies virus: a new class of molecules with antiviral activity.
Liang HR; Hu GQ; Xue XH; Li L; Zheng XX; Gao YW; Yang ST; Xia XZ
Virus Res; 2014 May; 184():7-13. PubMed ID: 24486485
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.
Du Pont V; Wirblich C; Yoon JJ; Cox RM; Schnell MJ; Plemper RK
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321812
[TBL] [Abstract][Full Text] [Related]
7. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
[TBL] [Abstract][Full Text] [Related]
8. Pentagalloylglucose Inhibits the Replication of Rabies Virus via Mediation of the miR-455/SOCS3/STAT3/IL-6 Pathway.
Tu Z; Xu M; Zhang J; Feng Y; Hao Z; Tu C; Liu Y
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243136
[TBL] [Abstract][Full Text] [Related]
9. Broad spectrum compounds targeting early stages of rabies virus (RABV) infection.
Kali S; Jallet C; Azebi S; Cokelaer T; Da Fonseca JP; Wu Y; Barbier J; Cintrat JC; Gillet D; Tordo N
Antiviral Res; 2021 Apr; 188():105016. PubMed ID: 33444703
[TBL] [Abstract][Full Text] [Related]
10. The Role of Heparan Sulfate Proteoglycans as an Attachment Factor for Rabies Virus Entry and Infection.
Sasaki M; Anindita PD; Ito N; Sugiyama M; Carr M; Fukuhara H; Ose T; Maenaka K; Takada A; Hall WW; Orba Y; Sawa H
J Infect Dis; 2018 May; 217(11):1740-1749. PubMed ID: 29529215
[TBL] [Abstract][Full Text] [Related]
11. Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis.
Yamada K; Noguchi K; Kimitsuki K; Kaimori R; Saito N; Komeno T; Nakajima N; Furuta Y; Nishizono A
Antiviral Res; 2019 Dec; 172():104641. PubMed ID: 31672666
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluating the effect of Favipiravir treatment on rabies virus infection.
Banyard AC; Mansfield KL; Wu G; Selden D; Thorne L; Birch C; Koraka P; Osterhaus ADME; Fooks AR
Vaccine; 2019 Aug; 37(33):4686-4693. PubMed ID: 29132993
[TBL] [Abstract][Full Text] [Related]
13. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.
Du Pont V; Plemper RK; Schnell MJ
Curr Opin Virol; 2019 Apr; 35():1-13. PubMed ID: 30753961
[TBL] [Abstract][Full Text] [Related]
14. Aptamers targeting rabies virus-infected cells inhibit street rabies virus in vivo.
Liang HR; Hu GQ; Li L; Gao YW; Yang ST; Xia XZ
Int Immunopharmacol; 2014 Aug; 21(2):432-8. PubMed ID: 24735817
[TBL] [Abstract][Full Text] [Related]
15. Lipid Droplets Are Beneficial for Rabies Virus Replication by Facilitating Viral Budding.
Zhao J; Zeng Z; Chen Y; Liu W; Chen H; Fu ZF; Zhao L; Zhou M
J Virol; 2022 Jan; 96(2):e0147321. PubMed ID: 34757839
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
Yamada K; Noguchi K; Komeno T; Furuta Y; Nishizono A
J Infect Dis; 2016 Apr; 213(8):1253-61. PubMed ID: 26655300
[TBL] [Abstract][Full Text] [Related]
17. Integrin β1 Promotes Peripheral Entry by Rabies Virus.
Shuai L; Wang J; Zhao D; Wen Z; Ge J; He X; Wang X; Bu Z
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666383
[TBL] [Abstract][Full Text] [Related]
18. Interferon-λ Attenuates Rabies Virus Infection by Inducing Interferon-Stimulated Genes and Alleviating Neurological Inflammation.
Li Y; Zhao L; Luo Z; Zhang Y; Lv L; Zhao J; Sui B; Huang F; Cui M; Fu ZF; Zhou M
Viruses; 2020 Apr; 12(4):. PubMed ID: 32268591
[TBL] [Abstract][Full Text] [Related]
19. BCX4430 inhibits the replication of rabies virus by suppressing mTOR-dependent autophagy invitro.
Xie Y; Chi YL; Liu SQ; Zhu WY
Virology; 2023 Aug; 585():21-31. PubMed ID: 37267717
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rabies virus propagation in mouse neuroblastoma cells by an intrabody against the viral phosphoprotein.
Kaku Y; Noguchi A; Hotta K; Yamada A; Inoue S
Antiviral Res; 2011 Jul; 91(1):64-71. PubMed ID: 21569799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]